Healthcare -
Biotechnology - NASDAQ - GB
$ 1.189
-0.917 %
$ 15 M
Market Cap
-0.48
P/E
AKTX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities AKTX - Akari Therapeutics, Plc
7.02 M
LAST VALUE
-29.92%
2 YEAR CAGR
87.12%
5 YEAR CAGR
-5.22%
10 YEAR CAGR